as Egypt suffered a lot during the pandemic of COVID 19 with limited drug choices, many of the patients could not acheive viral clearence with the standard module of care teh idea of introduction of new medications in the treatment protocol of COVID 19 managment. Ivermectin had shown a promising results in vitro studies and in limited in vivo studies. this clinical trial may open a new hope for COVID 19 patients as a new and cheap line of treatment
the study will compare the effect of ivermectin in comaprison and addition to the standard
mode of care for the COVID 19 patients
Drug: Ivermectin
use of Ivermectin in the treatment of COVID 19 patients, in comparison to and in addition to the standard care of treatment of COVID 19 in Egypt
Other Name: hydroxychloroquine
Inclusion Criteria:
- Asymptomatic mild cases and moderate cases proven to be infected by COVID 19 by viral
RNA swap
Exclusion Criteria:
- Contraindications for the drug: hypersensitivity.
- Any medications with possible drug interactions.
- Severe cases.
- Any malignant condition.
- Pregnant females.
- Breast feeding females.
- Any patient on the following medications: Erdafitinib- Lasmiditan- Quinidine due to
potential severe drug interaction.
isolation and referal hospitals for COVID 19 patients
Cairo, Egypt
Investigator: ehab ah kamal, MD
Contact: 01006162663
ehab ah kamal, MD
01006162663
ehabkamal2011@hotmail.com
noha mo asem, MD
houssam ho masoud, MD, Study Director
COVID sceintific comittee ministry of health and population